Prevail Therapeutics is based out of New York. Prevail Therapeutics Inc. operates as a biotechnology company. The Company develops gene therapies for patients with parkinson's disease and neurodegenerative disorders. Prevail Therapeutics serves patients and customers in the State of New York. The firm last filed a Form D notice of exempt offering of securities on 2018-03-14. The notice included securities offered of Equity
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
PREVAIL THERAPEUTICS INC.430 EAST 29TH STREET, SUITE 940
NEW YORK NY 10016
Business Phone: 917-336-9310
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)